Fennec Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Fennec Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Fennec Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Fennec Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $100k | 13k | 7.70 |
| 2025-09-30 | $90k | 9.6k | 9.36 |
| 2025-06-30 | $126k | 15k | 8.30 |
| 2025-03-31 | $73k | 12k | 6.09 |
| 2024-12-31 | $99k | 16k | 6.32 |
| 2024-06-30 | $28k | 4.5k | 6.11 |
| 2023-12-31 | $109k | 9.7k | 11.22 |
| 2023-09-30 | $73k | 9.7k | 7.51 |
| 2023-06-30 | $86k | 9.7k | 8.83 |
| 2020-06-30 | $95k | 11k | 8.35 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors